Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
分享投资, officially known as 深圳市分享成长投资管理有限公司, was founded in 2007 and is based in Shenzhen, China. The firm is one of the earliest professional venture capital firms in China, managing over 10 billion RMB across a professional investment team of over 50 members. Its investor base includes government guidance funds, university endowments, publicly listed companies, and notable entrepreneurs.
分享投资 targets early to mid-stage investments in three main themes: healthcare, consumer innovation, and hardcore technology. In healthcare, the firm invests in biotechnology, new drug development, and advanced medical devices. Consumer innovation projects focus on redefining traditional industry value chains, while hardcore technology investments emphasize AI, intelligent manufacturing, and new energy.
分享投资 has backed over 200 companies, including notable names such as 美年健康 (Meinian Health), the first health examination group listed on the A-share market; 华大基因 (BGI), a leader in life sciences and genomics; 步长制药 (Buchang Pharma), known for traditional Chinese medicine; 泽璟制药 (Zai Lab), specializing in oncology drug development; and 完美世界 (Perfect World), a comprehensive cultural and entertainment group.
Submit your pitch through their form at https://sharecapital.cn.
分享投资 often leads rounds, particularly in early to mid-stage investments where they can provide significant support and resources.
The firm actively participates in follow-on investments to support portfolio companies as they grow and scale.
分享投资 manages funds exceeding 10 billion RMB, allowing for substantial investments across various sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.